Retroviral vector and its use in gene therapy

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/86 (2006.01) A61K 31/70 (2006.01) A61K 35/12 (2006.01) A61K 48/00 (2006.01) C12N 15/867 (2006.01)

Patent

CA 2243529

DNA sequences for creating replication defective retroviral vector producer cells either in vivo, or in vitro for reimplantation. The retroviral vector comprises at least one heterologous gene and functional env and gag-pol genes are absent from the vector so that retrovirus structural proteins are not expressed by the target cells infected and transduced by the vector.

L'invention porte sur des séquences d'ADN utilisées pour créer, soit in vivo soit en vitro, une réplication de cellules productrices d'un vecteur de rétrovirus déficient, en vue de leur réimplantation. Le vecteur de rétrovirus, qui contient au moins un gène hétérologue, ne contient aucun gène fonctionnel env et gag-pol, de sorte que les protéines structurelles du rétrovirus ne sont pas exprimées par les cellules cibles infectées, transduites par le vecteur.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Retroviral vector and its use in gene therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Retroviral vector and its use in gene therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retroviral vector and its use in gene therapy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1792906

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.